184 related articles for article (PubMed ID: 36314067)
21. Transketolase of Staphylococcus aureus in the Control of Master Regulators of Stress Response During Infection.
Tan X; Ramond E; Jamet A; Barnier JP; Decaux-Tramoni B; Dupuis M; Euphrasie D; Tros F; Nemazanyy I; Ziveri J; Nassif X; Charbit A; Coureuil M
J Infect Dis; 2019 Nov; 220(12):1967-1976. PubMed ID: 31420648
[TBL] [Abstract][Full Text] [Related]
22. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.
Tong L; Chen Z; Li Y; Wang X; Yang C; Li Y; Zhu Y; Lu Y; Liu Q; Xu N; Shao S; Wu L; Zhang P; Wu G; Wu X; Chen X; Fang J; Jia R; Xu T; Li B; Zheng L; Liu J; Tong X
Cell Metab; 2024 May; 36(5):1013-1029.e5. PubMed ID: 38547864
[TBL] [Abstract][Full Text] [Related]
23. Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.
Wang S; Wang Y; Xun X; Zhang C; Xiang X; Cheng Q; Hu S; Li Z; Zhu J
J Exp Clin Cancer Res; 2020 Jan; 39(1):22. PubMed ID: 31992334
[TBL] [Abstract][Full Text] [Related]
24. Effect of transketolase modifications on carbon flow to the purine-nucleotide pathway in Corynebacterium ammoniagenes.
Kamada N; Yasuhara A; Takano Y; Nakano T; Ikeda M
Appl Microbiol Biotechnol; 2001 Sep; 56(5-6):710-7. PubMed ID: 11601619
[TBL] [Abstract][Full Text] [Related]
25. Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.
Liu Q; Zhu F; Liu X; Lu Y; Yao K; Tian N; Tong L; Figge DA; Wang X; Han Y; Li Y; Zhu Y; Hu L; Ji Y; Xu N; Li D; Gu X; Liang R; Gan G; Wu L; Zhang P; Xu T; Hu H; Hu Z; Xu H; Ye D; Yang H; Li B; Tong X
Nat Metab; 2022 May; 4(5):559-574. PubMed ID: 35606596
[TBL] [Abstract][Full Text] [Related]
26. Transketolase Activity but not Thiamine Membrane Transport Change in Response to Hyperglycaemia and Kidney Dysfunction.
Chalásová K; Pácal L; Pleskačová A; Knopfová L; Řehořová J; Tomandlová M; Tomandl J; Kaňková K
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):255-262. PubMed ID: 28950391
[TBL] [Abstract][Full Text] [Related]
27. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
28. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
29. A δ38 deletion variant of human transketolase as a model of transketolase-like protein 1 exhibits no enzymatic activity.
Schneider S; Lüdtke S; Schröder-Tittmann K; Wechsler C; Meyer D; Tittmann K
PLoS One; 2012; 7(10):e48321. PubMed ID: 23118983
[TBL] [Abstract][Full Text] [Related]
30. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
[TBL] [Abstract][Full Text] [Related]
31. Cloning, expression and characterization of sugarcane (Saccharum officinarum L.) transketolase.
Kalhori N; Nulit R; Go R
Protein J; 2013 Oct; 32(7):551-9. PubMed ID: 24132392
[TBL] [Abstract][Full Text] [Related]
32. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
33. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
[TBL] [Abstract][Full Text] [Related]
34. Megacell phenotype and its relation to metabolic alterations in transketolase deficient strain of Bacillus pumilus.
Srivastava RK; Jaiswal R; Panda D; Wangikar PP
Biotechnol Bioeng; 2009 Apr; 102(5):1387-97. PubMed ID: 19039788
[TBL] [Abstract][Full Text] [Related]
35. Isoginkgetin, a potential CDK6 inhibitor, suppresses
Yao J; Tang S; Shi C; Lin Y; Ge L; Chen Q; Ou B; Liu D; Miao Y; Xie Q; Tang X; Fei J; Yang G; Tian J; Zeng X
Autophagy; 2023 Apr; 19(4):1221-1238. PubMed ID: 36048765
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer.
Zhang L; Huang Z; Cai Q; Zhao C; Xiao Y; Quan X; Tang C; Gao J
Front Med (Lausanne); 2022; 9():837143. PubMed ID: 35280908
[TBL] [Abstract][Full Text] [Related]
37. Rhubarb granule promotes diethylnitrosamine-induced liver tumorigenesis by activating the oxidative branch of pentose phosphate pathway via G6PD in rats.
Huang H; Liu Z; Qi X; Gao N; Chang J; Yang M; Na S; Liu Y; Song R; Li L; Chen G; Zhou H
J Ethnopharmacol; 2021 Dec; 281():114479. PubMed ID: 34343647
[TBL] [Abstract][Full Text] [Related]
38. Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis.
Wani NA; Zhang B; Teng KY; Barajas JM; Motiwala T; Hu P; Yu L; Brüschweiler R; Ghoshal K; Jacob ST
Mol Cancer Res; 2018 Feb; 16(2):256-268. PubMed ID: 29187559
[TBL] [Abstract][Full Text] [Related]
39. Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression.
Ge LL; Wang H; Zhang YH; Wang HJ; Li L
J Cancer; 2024; 15(7):1826-1836. PubMed ID: 38434975
[No Abstract] [Full Text] [Related]
40. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
